跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ENSPRYNG 120 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ENSPRYNG 120 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
ENSPRYNG 120 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA
Roche Registration Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 26, 2021
Approval ID
67d1f76ca1b6e16a
Company
Roche Registration Gmbh
Type
Standard
Approval Details
Approval Id
67d1f76ca1b6e16a
Drug Cima Aemps Name
ENSPRYNG 120 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number
1211559001
Holder Company Name
Roche Registration Gmbh
Marketing Company Name
Roche Farma S.A.
Holder Company Detail Path
/organization/roche-registration-gmbh
Authorization Date
2021-07-26
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
120 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Roche Registration Gmbh
Company Detail Path
/organization/roche-registration-gmbh
Company Information
Pharmaceutical Company Name
Roche Registration GmbH
Country Name
Germany
City Name
grenzach-wyhlen,baden-württemberg,country_de
Address
Emil-Barell-Str. 1
Active Ingredients
SATRALIZUMAB
120 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 26, 2021
Approval ID
67d1f76ca1b6e16a
Type
Standard
Back to CIMA-AEMPS Approvals